Oracle Investment Management Inc Amarin Corp Plcuk Call Options Transaction History

Oracle Investment Management Inc

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $166,348 - $354,632	-45,700 Reduced 13.02%	305,300 $8,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $6.43 Million - $34.6 Million	-1,608,600 Reduced 82.09%	351,000 $2,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $25.6 Million - $44.4 Million	1,839,600 Added 1533.0%	1,959,600 $7.66 Million
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $7.37 Million - $12.3 Million	-530,700 Reduced 81.56%	120,000 $108,000
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $7.9 Million - $9.95 Million	485,300 Added 293.41%	650,700 $478,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $824,694 - $1.46 Million	65,400 Added 65.4%	165,400 $410,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $1.24 Million - $2.3 Million	100,000 New	100,000 $4,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $181M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.